Companies: 49,246 Total Market Cap: 132591774254860.43

Coloplast A/S

CPH-COLO.B
Healthcare Medical Instruments & Supplies
Rank #958
Market Cap 21.76 B
Volume 40,299
Price 97.47
Change (%) 0.84%
Country or region Denmark Denmark

Coloplast A/S's latest marketcap:

21.76 B

As of 05/20/2025, Coloplast A/S's market capitalization has reached $21.76 B. According to our data, Coloplast A/S is the 958th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 21.76 B
Revenue (ttm) 4.18 B
Net Income (ttm) 683.51 M
Shares Out 225.17 M
EPS (ttm) 3.03
Forward PE 25.70
Ex-Dividend Date 05/08/2025
Earnings Date 05/06/2025
Market Cap Chart
Data Updated: 05/20/2025

Coloplast A/S's yearly market capitalization.

Coloplast A/S has seen its market value drop from kr197.71 B to kr144.69 B since 2020, representing a total decrease of 26.82% and an annual compound decline rate (CAGR) of 6.87%.
Date Market Cap Change (%)
05/20/2025 kr144.69 B -18.02%
12/30/2024 kr177.00 B 2.05%
12/29/2023 kr173.44 B 0.54%
12/30/2022 kr172.51 B -29.57%
12/30/2021 kr244.93 B 23.89%
12/30/2020 kr197.71 B

Company Profile

About Coloplast A/S

Coloplast A/S is a global leader in developing and selling intimate healthcare products and services. Headquartered in Humlebæk, Denmark, the company operates in multiple countries, including Denmark, the United States, the United Kingdom, and France.

Business Segments

  • Chronic Care: Focuses on ostomy care solutions.
  • Continence Care: Provides products for urinary and bowel management.
  • Voice and Respiratory Care: Offers solutions for laryngectomy and tracheostomy care.
  • Interventional Urology: Specializes in surgical treatments for urological and gynecological disorders.
  • Advanced Wound Care: Delivers innovative wound and skin care products.

Key Products

  • Ostomy Care: SenSura Mio, SenSura Ostomy care solutions, and Brava accessories.
  • Continence Care: Conveen Active urine bags, SpeediCath catheters, and Peristeen Plus.
  • Wound & Skin Care: Biatain Silicone dressings, Comfeel hydrocolloid dressings, and InterDry skin fold management.
  • Voice & Respiratory: Provox voice prostheses, Tracoe tracheostomy products, and HMEs.
  • Interventional Urology: Solutions for urinary stone diseases, benign prostate hyperplasia, and erectile dysfunction.

Founded in 1954, Coloplast A/S continues to innovate in intimate healthcare, improving quality of life for patients worldwide.

Frequently Asked Questions

As of 05/20/2025, Coloplast A/S (including the parent company, if applicable) has an estimated market capitalization of $21.76 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Coloplast A/S global market capitalization ranking is approximately 958 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Denmark
Founded 1954
IPO Date n/a
Employees 16,639
CEO Kristian Villumsen
Sector Healthcare
Industry Medical Instruments & Supplies
Address Holtedam 1-3
Humlebæk, 3050
Denmark
Website https://www.coloplast.com
People Also Watch
ISRG
561.63 0.84%
EPA-EL
293.40 0.84%
BDX
176.44 0.84%
Alcon
88.80 0.84%